Hematological clues and how patients respond to nerve blocks for neuropathic pain
Official title: Hematological Inflammatory Indices as Predictors of Treatment Response to Sympathetic Nerve Blocks in Neuropathic Pain: A Prospective Observational Study
Run by Ankara City Hospital Bilkent · NCT07596823 · Data updated 2026-11-12
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Cankaya) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07596823 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with neuropathic pain (DN4 ≥ 4 or LANSS compatible) scheduled for a sympathetic nerve block and with available pre- and post-treatment blood tests.
✕Probably not a fit
Patients who do not show a correlation between inflammatory indices and pain response or who have confounding inflammatory conditions may not derive predictive benefit from the biomarkers studied.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, non-interventional study conducted at a single center to explore whether routine blood test inflammation indices reflect treatment response in adults with neuropathic pain receiving sympathetic nerve blocks as part of standard care. Researchers will measure markers such as NLR, PLR, MLR, SII, SIRI, AISI, and RDW before and after the procedure over three months, and relate changes to pain scores and analgesic use. The study uses clinical assessments like NRS, DN4 or LANSS, Global Perceived Effect, and patterns of analgesic consumption to gauge outcomes. The approach is observational and aims to identify potential blood-based biomarkers associated with treatment response. Results could inform future trials and patient monitoring strategies in neuropathic pain management.
Why it matters
Potential benefit: If successful, clinicians may use simple blood tests to help predict which patients will respond to sympathetic nerve blocks and tailor treatment plans accordingly.
How similar studies have gone: Previous work has explored inflammatory markers in chronic pain, but data linking hematological indices to response after sympathetic nerve blocks in neuropathic pain are limited and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Diagnosis of neuropathic pain based on clinical evaluation * DN4 and/or LANSS scores compatible with neuropathic pain * Undergoing sympathetic nerve block as part of routine clinical treatment * Availability of pre-treatment and follow-up hemogram parameters * Ability to provide written informed consent Exclusion Criteria: * Age \<18 years * Active infection or acute inflammatory disease * Active malignancy * History of hematological disease * Immunosuppressive therapy or systemic corticosteroid use * Major surgery or severe trauma within the last month * Pregnancy or breastfeeding * Autoimmune or rheumatologic inflammatory disease * Missing follow-up data
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Cankaya, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ülkü Sabuncu, Assoc prof
- Email: sabuncuulku@gmail.com
- Phone: 905337085212
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Cord plasma eye drops to treat neuropathic corneal pain
This trial will test whether cord plasma eye drops can reduce long-lasting nerve-related corneal pain in people with evidence of corneal nerve damage.
-
Comparing different NSAIDs plus home exercises for frozen shoulder
This will test whether taking one of several NSAIDs (diclofenac, meloxicam, or indomethacin) together with home shoulder exercises helps adults aged 18–75 with frozen shoulder and whether pain type changes the benefit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.